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Abstract
Purpose:  The  aim  of  our  retrospective  study  was  to  evaluate  the  efﬁcacy  of  interstitial  laser
photocoagulation  for  the  treatment  of  osteoid  osteomas  and  to  identify  the  factors  leading  to
failure of  the  procedure.
Material  and  methods:  Thirty-ﬁve  patients  received  interstitial  laser  photocoagulation  treat-
ment. A  minimum  of  3  months  follow-up  was  required.  The  laser  ﬁbre  was  positioned  within
the nidus  under  CT  guidance,  and  energy  between  500  and  1800  J  was  delivered  at  a  power  of
2 Watts/s.  Follow-up  was  by  outpatient  appointment  and  through  a  questionnaire  sent  to  the
patients.
Results:  Thirty  patients  replied  to  the  questionnaire.  Mean  follow-up  was  40  months.  The  tech-
nical success  rate  was  100%.  The  primary  success  rate  (no  pain  at  1  month)  was  94.3%.  The  rate
of recurrence  was  6%.  The  rate  of  complications  was  11.4%  (a  skin  burn,  patellar  enthesopathy,
a broken  item  of  material,  sacro-iliac  ﬁbrous  alterations).  Factors  likely  to  favour  failure  of  the
procedure are  the  size  of  the  nidus  (P  =  0.04)  and  poor  positioning  of  the  laser  ﬁbre  (P  =  0.03).
Conclusion:  Interstitial  laser  photocoagulation  is  an  effective  and  safe  treatment  for  osteoid
osteomas.
© 2013  Published  by  Elsevier  Masson  SAS  on  behalf  of  the  Éditions  françaises  de  radiologie.
IntroductionOsteoid  osteomas  [1]  are  relatively  frequent  benign  bone  tumours  [2]  (10  to  20%  of  benign
bone  tumours),  which  most  often  occur  during  the  ﬁrst  30  years  of  life  (90%  of  patients
are  less  than  25  years  old)  with  male  predominance  (sex-ratio  2:  1).  The  main  symptom  is
Abbreviations: ILP, Interstitial laser photocoagulation; J, Joule; G, Gauge.
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dInterstitial  laser  photocoagulation  for  the  treatment  of  oste
pain,  predominantly  nocturnal  and  typically  relieved  by  non-
steroidal  anti-inﬂammatory  drugs.  The  imaging  appearance
is  often  typical  [3,4], in  particular  in  a  CT  scan  where  the
nidus  is  hypodense  in  a  reactive  osteosclerosis  of  variable
abundance.  MRI  reveals  the  nidus,  which  has  a  variable  sig-
nal  and  is  enhanced  after  gadolinium  injection,  with  oedema
of  the  peripheral  cancellous  bone  and  soft  tissue  [5].  The
nidus  is  usually  less  than  2  cm  in  size,  which  distinguishes  it
from  an  osteoblastoma  [6].  More  than  50%  of  their  locations
are  in  the  femur  or  tibia.
The  problem  posed  by  this  tumour  is  disabling  pain
[7].  The  reference  treatment  used  to  be  surgical  [8,9],
curing  patients  by  complete  excision  of  the  nidus.  The  dif-
ﬁculties  of  peroperative  location  of  the  nidus  within  the
reactive  osteosclerosis  often  resulted  in  extensive  excisions
responsible  for  complications  (bone  fragilisation  and  frac-
tures).  CT-guided  minimally  invasive  therapies  were  then
developed:  ﬁrst,  percutaneous  CT-guided  excision  [10], then
radiofrequency  ablation  [11—16]  and  ﬁnally  interstitial  laser
photocoagulation  (ILP)  [17—23]. The  nidus  could  be  located
by  CT  scanning  and  the  latter  two  techniques  limited  fra-
gilisation  of  the  bone.
For  ILP  treatment,  a  laser  generator  (a  Dornier  Medilas
D  Fibertom  diode  laser  from  Bernas  Medical®)  is  used  at
low  energy.  The  light  energy  is  transmitted  to  the  tumour
through  a  400  m  diameter  optical  ﬁbre  and  converted  into
heat  energy  on  diffusing  into  the  tissue.  The  rise  in  tempe-
rature  causes  denaturation  of  the  proteins  and  consequently
cell  necrosis.  The  thermal  properties  of  tissues  depend  on
their  water  content,  making  the  size  of  the  necrosis  pre-
dictable.  The  study  of  the  thermal  properties  of  bone  has
shown  that  the  degree  of  thermal  sensitivity  changes  very
little  between  cortical  and  trabecular  bone  and  bone  mar-
row.  The  necrosis  threshold  is  an  exposure  to  50 ◦C  for  30  s.
We  chose  this  technique  because  it  has  several  advan-
tages  over  radiofrequency:  it  is  not  necessary  to  insert  a
neutral  electrode,  no  current  ﬂows  through  the  patient’s
body,  there  is  no  interaction  with  pacemakers,  stimulators
or  metal  structures,  the  cost  of  the  laser  ﬁbre  is  low,  and
disposable  ﬁbres  reduce  the  risk  of  contamination.  Previ-
ous  studies  have  conﬁrmed  that  this  treatment  of  osteoid
osteomas  is  effective  and  safe  [17—23].
The  aim  of  our  study  was  to  retrospectively  evaluate  the
results  of  this  technique  in  our  centre  for  the  treatment
of  osteoid  osteomas  and  to  identify  the  factors  that  might
induce  the  procedure  to  fail.
Material and methods
Patients
Between  3rd  October  2001  and  16th  November  2011,
35  patients  underwent  ILP  in  two  different  centres:  the
paediatric  radiology  department  and  the  adult  radio-
logy  department.  Our  retrospective  study  did  not  require
approval  by  an  ethics  committee.  The  age  of  patients  ranged
from  3  to  69  years  old  (mean:  21.7  years  old).  Our  popu-
lation  consisted  of  27  males  and  eight  females,  giving  a
sex-ratio  of  3.4:1.  The  lesions  were  located  in  the  femur
(n  =  19),  tibia  (n  =  7),  patella  (n  =  2),  ulna  (n  =  1),  iliac  bone
(n  =  1),  sacrum  (n  =  1),  calcaneus  (n  =  1),  the  neck  of  the  talus
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n  =  1),  humerus  (n  =  1)  and  lateral  cuneiform  bone  (n  =  1)
Fig.  1).  Nine  of  these  lesions  had  articular  topography:  a
esion  of  the  olecranon  groove  of  the  humerus,  two  of  the
atella  located  respectively  at  8  mm  and  6 mm  from  the
atellofemoral  joint  space,  three  of  the  acetabular  fossa
n  direct  contact  with  the  coxo-femoral  joint  space,  a  lesion
f  the  iliac  bone  4  mm  from  the  sacro-iliac  joint,  a  sacral
esion  in  contact  with  the  L5-S1  zygapophyseal  joint  4  mm
rom  the  nerve  root  where  it  passes  through  the  foramen
Fig.  2),  and  a  lesion  of  the  femoral  condyle  20  mm  from  the
emorotibial  joint  space.
Clinical  diagnosis  of  osteoid  osteoma  was  suspected  given
redominantly  nocturnal  pain,  not  related  to  physical  acti-
ity,  typically  relieved  by  NSAIDs  (26  patients  had  typical
linical  features).  Most  often  there  was  a  considerable  delay
n  diagnosis,  with  a mean  of  15  months  in  our  study.  The  clini-
al  suspicion  was  later  conﬁrmed  by  imaging  examinations
24,25].  All  the  patients  in  our  study  had  standard  X-rays
nd  a  CT  scan  and  sometimes  scintigraphy  (n  =  10)  or  MRI
n  =  6).  These  examinations  all  showed  the  nidus,  the  size  of
hich  was  less  than  20  mm.  Treatment  by  ILP  was  decided
n  a  multidisciplinary  musculoskeletal  oncology  consultative
eeting.  When  not  all  the  clinical  and  radiological  criteria
ere  met,  a  biopsy  was  performed  before  or  during  the  ILP
rocedure.  Five  biopsies  were  performed.
The  patients  included  in  our  study  were  treated  with  ILP
iven  the  clinical  symptoms  and  radiological  picture  sup-
orting  this  diagnosis,  and  a  minimum  period  of  3  months
linical  follow-up  was  required.  The  absence  of  histological
onﬁrmation  of  the  diagnosis  was  not  an  exclusion  criterion,
or  was  prior  treatment  having  been  performed.
rocedure
he  treatment  was  carried  out  in  aseptic  surgical  conditions
nd  under  general  anaesthesia,  since  entering  the  nidus  is
nown  to  be  extremely  painful  [26,27].
A CT  scout  scan  was  performed  to  verify  the  absence
f  morphological  changes  compared  with  the  diagnostic  CT
can,  and  to  conﬁrm  the  treatment  parameters  (precise
ocation  of  the  nidus,  its  situation  relative  to  vulnerable
natomical  features  —– joints,  nerve  roots,  tendons  etc.  —–
nd  calculation  of  the  energy  required  to  treat  the  tumour).
n  general,  the  approach  chosen  was  where  the  bone
istance  to  be  crossed  was  the  shortest.  Exceptionally,
uperﬁcial  subperiosteal  lesions  were  approached  from  the
pposite  side,  with  a  longer  path  through  the  bone  for
tabilising  the  laser  ﬁbre,  as  were  lesions  near  vulnerable
natomic  structures.
A  Bonopty  14G  needle  (Bonopty® Bone  Biopsy  System,
prioMed,  Uppsala  Sweden)  was  used  to  cross  the  corti-
al  bone  to  the  nidus,  then  an  18G  coaxial  needle  was
nserted  into  the  nidus  to  protect  the  400  m  laser  ﬁbre.
ince  the  ﬁbre  was  not  radiopaque,  a  marker  was  put  in
lace,  before  inserting  it  into  the  18G  needle  so  that  it
xtended  beyond  it  by  approximately  5  mm  into  the  nidus.
he  energy  (Dornier  Medilas  D  Fibertom  Bernas  Medical®
iode  laser  with  a  wavelength  of  940  nm)  was  then  deli-
ered  at  2  Watts/s  for  a  period  depending  on  the  size  of  the
idus:  nidus  size  ×  100  J  +  200  J.  When  the  nidus  was  at  a  dis-
ance  from  vulnerable  structures,  the  maximum  total  energy
f  1200  J  was  delivered.  A  14  mm  lesion  was  treated  by
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Figure 1. a: osteoid osteoma of the lateral cuneiform bone. Axial CT scan of the foot, hypodense nidus, calciﬁed in the centre, surrounded
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wy reactive osteosclerosis; b: coronal CT scan of the foot; c: scout C
idus.
lacing  the  laser  at  both  ends  of  the  lesion  (800  J  ×  2).  A
iopsy  for  histological  examination  was  taken  at  the  start
f  the  procedure  when  the  picture  was  not  typical.  One  ILP
as  cancelled  in  the  end  because  the  subpe-riosteal  lesion
ad  increased  in  size  and  changed  in  appearance.  It  proved
o  be  an  osteoblastoma.  CT  control  scans  were  performed
uring  and  at  the  end  of  the  procedure  to  ensure  correct
ositioning  of  the  trocar.
The  mean  duration  of  the  procedure  was  1  h.  Patients
tayed  in  hospital  overnight  in  the  orthopaedic  surgery
epartment  and  could  resume  weight-bearing  immediately.
valuation and follow-up
he  patients  had  appointments  with  the  orthopaedic  sur-
eons  at  varying  intervals.
A questionnaire  was  sent  to  patients,  or  completed  by
elephone  in  the  absence  of  a  written  response,  allow-
ng  later  assessment  of  the  persistence  of  pain,  analgesic
p
e
tan during the ILP procedure. d: bonopty needle in place within the
onsumption,  undesirable  effects  and  patient  satisfaction.
hirty  patients  replied  to  the  questionnaire.
We  assessed  the  technical  success,  deﬁned  as  the  posi-
ioning  of  the  laser  ﬁbre  within  the  nidus  so  that  the  desired
nergy  could  be  delivered,  the  primary  success,  in  terms
f  disappearance  of  pain  1  month  after  the  procedure,  the
ailure,  in  terms  of  the  persistence  of  pain  1  month  after
reatment,  the  recurrence,  in  terms  of  recurrence  of  symp-
oms  more  than  1  month  after  treatment  following  initial
elief  of  pain,  the  complications,  and  the  risk  factors  for  fail-
re  of  the  procedure.  The  criteria  that  we  considered  were
ge,  sex,  size  of  the  nidus,  the  energy  delivered,  intra-  or
xtra-articular  topography,  and  the  positioning  of  the  laser
bre.  The  position  of  the  laser  ﬁbre  was  determined  retro-
pectively:  it  was  considered  as  good  when  the  laser  ﬁbre
as  at  the  centre  of  the  nidus  in  all  three  spatial  planes,  as
oor  when  it  was  only  centred  in  one  spatial  plane  or  was
ccentric  in  all  three  planes.
We  did  not  perform  systematic  control  imaging  examina-
ions  in  our  study  where  evolution  was  favourable,  except
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tigure 2. ( Continued )
igure 2. a: osteoid osteoma of the left L5/S1 zygapophyseal joint. Bo
eft sacral ala; b: tomoscintigraphy combined with a CT scan: the focu
he scan surrounding a hypodense lesion, the nidus; c: axial T1-weighte
nto contact with the joint; the nidus gives an intermediate T1-weighte
la peripheral to the nidus and peripheral soft tissues. The nidus is hete
alciﬁcations; e: axial T1-weighted fat sat. sequence after gadolinium in
elated to the perilesional oedema that can mimic an aggressive lesion;
he nerve roots, calciﬁed in the centre, surrounded by reactive osteosclne scintigraphy (TechniScan HDP Tc-99 m): increased uptake in the
s with increased uptake corresponds to a ﬁeld of condensation on
d MRI of the pelvis, hypointense ﬁeld in the left sacral ala coming
d signal; d: axial STIR sequence: hyperintensity of the left sacral
rogeneous, hyperintense with hypointense areas corresponding to
jection: enhancement of the nidus, peripheral bone and soft tissue
 f: scout CT scan during the ILP procedure: hypodense nidus near
erosis; g: bonopty needle in place within the nidus.
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(Interstitial  laser  photocoagulation  for  the  treatment  of  oste
for  seven  patients:  six  of  them  who  were  monitored  in  paedi-
atrics  had  a  CT  scan  after  6  months;  one  patient  monitored  in
the  adult  orthopaedic  surgery  unit  and  treated  for  an  L5/S1
zygapophyseal  joint  lesion  had  an  MRI  scan  after  4  months.
Results
The  technical  success  rate  was  100%.
The  mean  follow-up  of  patients  was  40  months
(3—122  months).  Thirty  patients  replied  to  the  ques-
tionnaire,  so  that  the  duration  of  follow-up  could  be
prolonged  and  information  missing  from  the  ﬁles  com-
pleted.  Monitoring  pain  was  the  main  purpose  of  the
follow-up.  We  did  not  use  a  visual  analogue  scale  but
considered  a  binary  result:  persistence  or  not  of  pain,  since
total  absence  of  pain  is  expected  after  treatment.
The  primary  success  rate  was  estimated  at  94.3%  (33
primary  successes).  Two  failures  occurred,  the  ﬁrst  in  a  17-
year-old  patient  with  an  intra-articular,  10  mm  nidus  of  the
acetabular  fossa  treated  with  1100  J.  The  second  was  in  a
22-year-old  patient  who  had  a  13  mm  extra-articular  cortical
nidus  treated  with  1200  J.
The  rate  of  recurrence  was  estimated  at  6%,  which  corre-
sponds  to  two  patients,  the  recurrences  occurring  at  2  and
17  months  after  the  initial  treatment.  They  involved  a  20-
year-old  patient  and  a  17-year-old,  whose  nidi  measured
8  and  12  mm,  and  were  treated  respectively  with  900  and
1200  J.  For  the  12  mm  nidus,  the  laser  ﬁbre  had  been  poorly
positioned.  For  the  8  mm  nidus,  it  was  indeed  a  recurrence,
with  the  development  of  a  new  nidus  close  to  the  ﬁrst.
One  of  the  four  patients  treated,  in  whom  there  had
been  failure  or  recurrence,  had  his  pain  relieved  after  a
second  procedure.  Two  of  the  three  patients  still  with  pain
underwent  a  third  procedure  with  success.  The  third  patient
did  not  want  any  additional  procedure,  was  not  satisﬁed
with  the  treatment,  and  is  still  taking  analgesics  after  two
failures.  The  characteristics  of  the  osteomas  and  the  thera-
peutic  results  are  summarised  in  Table  1.
Complications
The  complication  rate  in  our  study  was  11.4%.  The  four
complications  were  a  skin  burn  due  to  migration  of  the  opti-
cal  ﬁbre  requiring  covering  with  a  skin  ﬂap,  a  patellar  tendon
enthesopathy  appearing  in  the  ultrasound  examination  in
a  female  patient  treated  for  a  patellar  nidus,  breakage
of  an  item  of  material  (a  Bonopty  needle)  at  the  end  of
the  procedure  requiring  corticotomy,  and  bone  lacunae  in
contact  with  the  sacro-iliac  joint  after  treatment  of  a  nidus
located  4  mm  from  the  joint  space,  which  proved  on  his-
tological  examination  to  be  ﬁbrous  tissue.  These  various
complications  caused  no  long-term  discomfort.Histopathology
Only  ﬁve  biopsies  were  performed  for  histological  conﬁrma-
tion  of  the  diagnosis,  and  only  one  was  positive.  For  the
other  four  patients,  the  histological  diagnosis  could  not  be
determined  because  there  was  not  enough  lesion  tissue.
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ailure factors
nly  the  size  of  the  nidus  (P  =  0.04)  and  the  position  of  the
aser  ﬁbre  (P  =  0.03)  were  associated  signiﬁcantly  with  a  risk
f  failure  (Table  2).
iscussion
steoid  osteoma  is  a  benign  bone  tumour  with  no  risk  of
alignant  degeneration.  Spontaneous  involution  has  been
escribed.  Its  small  size,  usually  less  than  2  cm,  makes  it
ccessible  to  ILP  treatment.  This  method  is  described  as
afe  and  effective  in  the  literature,  particularly  because  the
olume  of  necrosis  depending  on  the  amount  of  energy  deliv-
red  is  well  controlled.  Destruction  of  the  nidus  by  heating
tops  the  painful  phenomena.
There  was  no  technical  failure  in  our  study.  Thirty-three
f  the  35  patients  initially  had  their  pain  relieved.  The
rimary  success  rate  was  thus  94.3%  and  the  failure  rate
.7%.  Two  patients  had  a recurrence  after  2  and  17  months.
ain  relief  was  obtained  in  one  out  of  four  patients  who
nderwent  a  second  procedure.  Two  of  the  remaining  three
nderwent  a  third  procedure  and  obtained  relief.  These
esults  are  not  as  good  as  those  reported  in  other  studies
Table  3).  The  largest  published  series,  that  of  Gangi  et  al.
28]  included  114  patients,  the  primary  success  rate  was
9.1%  (n  =  113),  the  rate  of  recurrence  5.3%  (n  =  6)  and  the
econdary  success  rate  100%  (n  =  6).  The  failure  was  related
o  a  state  of  agitation  during  a  procedure  under  local  anaes-
hesia,  which  only  allowed  300  J  to  be  administered.  In  this
tudy,  the  laser  ﬁbre  delivered  energy  of  2 Watts  for  600  s
i.e.  1200  J)  for  lesions  at  a  distance  from  vulnerable  struc-
ures.  When  this  was  not  the  case,  the  energy  delivered  was
alculated  using  the  formula:  nidus  size  ×  100  J  +  200  J,  the
ize  of  the  nidus  being  in  millimetres.  Given  that  the  amount
f  coagulation  is  limited  (particularly  by  blood  ﬂow)  to  a
aximum  diameter  of  16  mm,  six  patients  whose  nidus  was
etween  15  and  24  mm  were  treated  using  the  laser  ﬁbre  in
everal  positions  in  the  nidus,  delivering  an  energy  total  of
000  to  3000  J.
In  our  study,  a  nidus  of  14  mm  4  mm  from  the  sacro-
liac  joint  was  treated  successfully  using  two  different
pproaches  delivering  2  ×  800  J.
In  the  study  by  Roqueplan  et  al.  [19], the  primary  success
ate  was  96%  (n  =  93/97),  the  rate  of  recurrence  3.1%  (n  =  3)
nd  the  secondary  success  rate  66.7%  (n  =  2/3).
An  alternative  treatment  to  ILP  is  CT-guided  radiofre-
uency  ablation.  A  radiofrequency  generator  produces
n  alternating  current  delivered  via  an  electrode  placed
ithin  the  nidus.  Ionic  agitation  of  the  tissues  causes
 rise  in  temperature:  at  more  than  60 ◦C  cell  damage
s  irreversible.  The  series  published  concerning  radiofre-
uency  ablation  report  primary  success  rates  lower  than  ours
Table  4).
Rosenthal  et  al.  [11]  reported  a primary  success  rate  of
9%  (n  =  112/126),  a failure  rate  of  11%  (n  =  14/126),  a  recur-
ence  rate  of  7%  (n  =  9/126),  a  secondary  success  rate  of
0%  (n  =  6/10).  Vanderschueren  et  al.  [15]  reported  an  over-
ll  success  rate  of  76%  (n  =  74/97),  a  recurrence  rate  of  11%
n  =  11),  a secondary  success  rate  of  50%  for  patients  with
arlier  failure  and  83%  for  those  who  had  had  a  recurrence.
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Table  1  Characteristics  of  osteoid  osteomas  and  the  treatments  performed.
No.  Age
(years)
Sex Site  of
nidus
Size  of
nidus
(mm)
Energy
delivered
(Joules)
Result  at
1  month
Recurrence  Follow-up
period
(months)
1 20 M  Tibia  8  900  S  Yes  108
2  18  M  Calcaneus  10  1200  S  No  45
3 17  M  Femur  10  1100  F  No  92
4 69 M Tibia 6  720  S  No  65
5 17 M Femur 7 840  S  No  22
6 21 M Tibia 9 1200 S No 20
7  35  F  Femur  6  1200  S  No  24
8  17  M  Femur  12  1200  S  No  39
9  70  M  Humerus  6  1200  S  No  32
10  24  F  Patella  4  1200  S  No  36
11  23  M  Ulna  4  1200  S  No  36
12  38  M  Femur  5  500  S  No  3
13  24  F  Femur  15  1200  S  No  36
14  28  M  Femur  7  960  S  No  3
15  18  M  Tibia  2  600  S  No  88
16  18  M  Femur  8  900  S  No  86
17  12  F  Femur  5  600  S  No  86
18  24  M  Tibia  5  800  S  No  96
19  13  M  Ilium  14  1600  S  No  122
20  13  F  Femur  6  800  S  No  3
21  18  F  Tibia  9  1000  S  No  57
22  7  M  Femur  7  750  S  No  37
23  7  F  Tibia  11  700  S  No  34
24  3  M  Femur  11  600  S  No  24
25  6  M  Femur  12  900  S  No  27
26  17  M  Cuneiform  8  900  S  No  23
27  13  M  Femur  8  700  S  No  20
28  13  M  Femur  6  850  S  No  10
29 17  M  Femur  12  1200  S  Yes  44
30  35  M  Femur  7  1200  S  No  12
31 16  M  Patella  6  1200  S  No  15
32 21 M  Talus  8  1200  S  No  43
33 23 M Sacrum  7  1100  S  No  6
34 22 F  Femur  4  1200  S  No  3
35 22 M Femur  13  1200  F  No  3
S: success; F: failure.
Table  2  Risk  factors  for  failure.
Successes
(n  =  31)
Failures
(n =  4)
Total
(n =  35)
P
Sex:  male  (%) 23  (77) 4  (100)  27  (80)  NS
Mean  age  in  years  (standard  deviation) 22.0  (15.1) 19.0  (2.4) 21.7  (14.2)  NS
Size  of  the  nidus  in  mm  (standard  deviation)  7.6  (3.0)  10.7  (2.2)  7.9  (3.1)  P  =  0.04a
Mean  energy  in  J  (standard  deviation)  974.0  (260.8)  1100.0  (141.4)  989.0  (281.8)  NS
Intra-articular  topography  (%)  9  (29)  1  (25)  10  (28)  NS
Poor  laser  position  (%)  5  (16)  3  (75)  8  (23)  P  =  0.03b
a Mann-Whitney test.
b Fisher exact test).
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Table  3  Result  of  laser  treatment  procedures  of  osteoid  osteomas.
N  Primary
successes
(%)
Failures
(%)
Recurrences
(%)
Secondary
successes
(%)
Complications
(%)
Histological
conﬁrmation
Gangi  et  al.  (2007)  [28] 114 113  (99)  1  (1)  6  (5)  6  (100)  1  (1)  67/88  (76)
Roqueplan  et  al.  (2010)  [19]  100  93/97  (96)  2/97  (2)  3/97  (3)  2/3  (67)  4  (4)  (64)
Witt  et  al.  (2000)  [18] 23 22  (96)  1  (4)  1  (4)  2  (100)  2  (9)  —
Zouari  et  al.  (2008)  [17] 15 15  (100) 0  (0) 1  (7)  1  (100)  1  (7)  —
Table  4 Result  of  radiofrequency  treatment  procedures  of  osteoid  osteomas.
n Primary
successes
(%)
Failures
(%)
Recurrences
(%)
Secondary
successes
(%)
Complications
(%)
Histological
conﬁrmation
Rosenthal  et  al.  (2003)  [11] 126  112  (89)  14  (11)  9  (7)  6/10  (60)  4/271  (2)  197/271
(73)
Vanderschueren  et  al.  (2002)  [15] 97 85 (88)  12  (12)  11  (11)  10/12  (83)a
5/10  (50)b
2  (2)  20/56  (36)
De  Berg  et  al.  (1995)  [13] 18 18 (100)  0 (0)  1  (6)  1/1  (100)  0  (0)  —
Hoffmann  et  al.  (2010)  [12] 38 38 (100)  0 (0)  3 (8)  3/3  (100)  4  (11)  14/29  (48)
Martel  et  al.  (2009)  [29] 10 8 (80)  2 (20)  0  (0)  2/2  (100)  0  (0)  —
a Failures.
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Complications
No  severe  complication  such  as  fracture  or  infection
occurred  in  our  study.
There  were  four  minor  complications:  breakage  of  a  piece
of  equipment,  a  patellar  enthesopathy,  a  bone  lacuna  and  a
skin  burn.  Our  rate  of  complications  was  11.4%.
Ten  percent  of  osteoid  osteomas  occur  in  the  spine,  most
often  in  the  posterior  arch.  In  our  centre,  they  are  still  often
treated  surgically,  for  fear  of  root  or  spinal  cord  lesions.
We  treated  a  nidus  in  contact  with  the  L5/S1  zygapophyseal
joint  and  4  mm  from  the  nerve  root  passing  through  the  fora-
men  with  1100  J,  without  a  cooling  technique  and  without
causing  neurological  complications.
The  spontaneous  cooling  effect  of  the  ﬂow  of  epidural
blood  and  CSF  has  been  suggested  by  Dupuy  et  al.  [30]  but
remains  difﬁcult  to  assess  in  practice,  so  that  some  authors
feel  justiﬁed  in  using  additional  cooling  procedures.
In  the  series  by  Gangi  et  al.  [28], 12  spinal  osteoid  osteo-
mas  were  treated  without  neurological  complications.  Five
of  them  were  within  8  mm  of  the  nerve  roots  and  a  slow  per-
fusion  of  epidural  or  periradicular  physiological  saline  was
used  to  protect  them.  Similarly,  for  the  nidi  in  contact  with
neurological  or  vascular  structures  and  for  intra-  or  juxta-
articular  nidi  an  injection  of  physiological  saline  was  given.
In  this  series,  only  one  complication  occurred,  a  case  of
reﬂex  sympathetic  dystrophy.  The  same  authors  [31]  also
advocate  the  use  of  epidurography  using  atmospheric  air  or
carbon  dioxide.
Treatment  of  osteomas  of  the  hands  or  feet  was  initially
controversial  because  of  the  risk  of  vascular,  tendon  and
cutaneous  complications.  We  treated  three  tarsal  lesions
l
f
[lateral  cuneiform,  neck  of  the  talus,  calcaneus)  with  no
omplications.  Several  studies  recommend  using  protective
ystems  in  these  situations.  Zouari  et  al.  [17]  have  treated
5  lesions  of  the  hands  and  feet  using  ILP.  When  the  distance
etween  the  lesion  and  the  skin,  tendon  or  nerve  structure
as  less  than  15  mm  for  the  carpus  or  tarsus  and  12  mm  for
he  phalanges,  an  injection  of  physiological  saline  was  given
o  increase  the  space  between  them.  No  complications  were
eported.
In  the  series  by  Roqueplan  et  al.  [19], the  rate  of
omplications  was  4%  and  included  contusion  of  the  peroneal
erve  resulting  in  a  deﬁcit  of  the  extensor  of  the  thumb,  a
aematoma  at  the  site  of  puncture,  a  superﬁcial  abscess,
nd  a  case  of  tendinitis.
For  radiofrequency  ablations,  Rosenthal  et  al.  [11]
escribed  3.2%  of  complications,  two  related  to  the
naesthesia  (cardio-respiratory  arrest,  inhalation)  and  two
elating  to  the  procedure  (reﬂex  sympathetic  dystrophy
nd  cellulitis).  Vanderschueren  et  al.  [15]  reported  two
omplications  (a  skin  burn  and  breakage  of  a  piece  of  equip-
ent),  i.e.  a  complication  rate  of  2.1%.
These  complication  rates  are  lower  than  those  described
or  surgical  treatment  or  CT-guided  percutaneous  resec-
ions  (Table  5).  For  surgical  treatment,  Sluga  et  al.  [9]
escribed  3%  of  fractures  after  curettage  and  4.5%  after
lock  resection.  Sans  et  al.  [10]  reported  a  complication  rate
f  24%,  including  two  fractures  and  chronic  focal  osteomyeli-
is  after  CT-guided  percutaneous  resection.
CT-guided  minimally  invasive  treatments  reduce  the
ength  of  hospital  stay  to  less  than  24  h  as  against  4.8  days
or  percutaneous  ablation  [10]  and  5  days  following  surgery
9].  Similarly,  no  period  without  weight-bearing  is  required,
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Table  5  Result  of  open  (Yildiz  et  al.)  or  percutaneous  (Sans  et  al.)  surgical  treatment  procedures  of  osteoid  osteomas.
n Primary
successes
(%)
Failures
(%)
Recurrences
(%)
Secondary
successes
(%)
Complications
(%)
Histological
conﬁrmation
Yildiz  et  al.  (2001)  [32] 105 99  (94) — — — — 105  (100)
Sans  et  al.  (1999)  [10] 38 28/32 (88)a — 6 (16) — 9 (24) 28/38  (74%)
a Excluding patients who had another histological diagnosis.
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dhich  means  that  children  need  not  interrupt  their  schooling
nd  the  period  off  work  for  adults  is  reduced.
istopathology
n  our  study,  of  the  ﬁve  biopsies  performed,  only  one  con-
rmed  the  diagnosis  of  osteoid  osteoma,  the  others  not
roviding  any  information.  Nevertheless,  we  think  that  the
ajority  of  these  biopsies  did  in  fact  correspond  to  osteoid
steomas.  Akhlaghpoor  et  al.  [33]  recommend  surgical  treat-
ent  in  cases  presenting  atypically.  In  their  study  of  39
atients,  the  rate  of  histological  conﬁrmation  was  69.2%
rom  the  bone  fragments  from  normal  drilling.  In  the  litera-
ure,  the  rate  of  diagnostic  conﬁrmation  in  radiofrequency
blation  with  a  biopsy  at  the  beginning  of  the  procedure  is
etween  36  and  100%  [11—13,15],  and  100%  after  surgery.
isk factors for failure or recurrence
wo  failures  occurred  in  our  study.  Re-examination  of  the
mages  showed  poor  positioning  of  the  laser  ﬁbre.
As  far  as  the  recurrences  are  concerned,  the  laser  ﬁbre
ad  been  incorrectly  positioned  in  the  ﬁrst  patient,  whereas
n  the  second  (occurring  at  17  months),  it  was  a  case  rather
f  the  appearance  of  a  new  nidus  close  to  the  ﬁrst.
Mean  nidus  size  was  7.6  mm  for  the  patients  who  obtained
ong-term  pain  relief  and  10.7  mm  for  the  patients  with  fail-
re  or  recurrence.
These  patients  underwent  a  second  treatment.  Three  of
hese  failed:  in  two  cases  the  laser  ﬁbre  was  positioned
ncorrectly  because  of  persistent  approach  problems.  As  for
he  third  patient,  the  laser  was  well  positioned  but  with
he  formation  of  air  bubbles  within  the  nidus.  The  pain
as  initially  relieved  but  recurred  13  months  later,  when
maging  showed  the  appearance  of  two  nidi  at  the  supe-
ior  and  inferior  poles  of  the  ﬁrst  lesion,  with  increased
ptake  in  scintigraphy.  They  were  successfully  treated  by
lacing  the  laser  ﬁbre  in  two  positions  delivering  2  ×  1200  J.
he  osteoma  of  the  acetabular  fossa  was  ﬁnally  successfully
reated  with  a  third  procedure,  the  laser  ﬁbre  having  been
orrectly  positioned.
For  our  statistical  analysis  of  risk  factors  for  failure  we
rouped  together  patients  with  primary  failure  and  those
ith  recurrence  (four  patients).  The  size  of  the  nidus  and
oor  positioning  of  the  laser  ﬁbre  are  signiﬁcant  factors  for
ailure  (P  =  0.04  and  P  =  0.03  respectively).  The  age,  sex,
ntra  or  extra-articular  topography  and  energy  delivered
ere  not  signiﬁcant.
n
p
t
nThese  results  are  consistent  with  those  of  Vander-
chueren  et  al.  [34]  who  have  studied  the  risk  factors
or  failure  of  radiofrequency  thermocoagulation.  Treat-
ent  failure  seems  to  occur  more  often  in  young  patients,
specially  where  the  nidus  is  large  and  the  laser  electrode
oorly  positioned.  The  use  of  a  single  electrode  position
eems  to  be  the  most  important  factor  for  failure.  Their
onclusion  is  that  using  multiple  trajectories  reduces  the  risk
f  failure,  especially  when  the  nidus  is  larger  than  10  mm.
he  location,  calciﬁcation  of  the  nidus,  coagulation  time,
ize  of  the  lesion,  the  learning  curve  and  previous  treat-
ents  are  not  independent  risk  factors.  Poor  positioning
ould  be  explained  by  difﬁculties  of  approach  (the  proxim-
ty  of  nerve  structures,  for  example)  or  poor  visualisation
f  the  nidus,  particularly  when  previous  treatment  has  been
erformed.
The  main  limitations  of  our  study  for  evaluating  the  fac-
ors  for  failure  or  recurrence  are  the  limited  size  of  our
ample,  the  low  number  of  patients  with  failure  of  the  pro-
edure,  retrospective  analysis  of  the  position  of  the  laser
bre,  which  was  not  performed  blind,  and  the  variable  char-
cter  of  the  energy  delivered,  initially  calculated  using  the
ormula  cited  above,  then  systematically  of  1200  J.
he place of post-therapeutic imaging
e  did  not  perform  systematic  control  imaging  examinations
n  our  study  if  the  condition  evolved  favourably,  except  in
even  patients.  Of  the  six  control  scans  at  6  months,  three
howed  a  completely  ossiﬁed  nidus,  two  a  decrease  in  the
ize  of  the  nidus  (5  mm  as  against  11  mm  and  4  mm  as  against
 mm  previously),  and  one  a  bone  lacuna.  The  control  MRI  at
 months  of  the  patient  treated  for  an  osteoma  of  the  L5/S1
ygapophyseal  joint  showed  a  reduction  in  STIR  hyperinten-
ity,  fat  recovery  on  the  T1-weighted  sequence  with  bone
yperintensity,  and  a  clear  decrease  in  enhancement  of  the
idus,  the  peripheral  bone  and  soft  tissue  after  gadolin-
um  injection.  The  scans  of  the  four  patients  with  failure
r  recurrence  all  revealed  stable  or  reduced  nidus  size.
Vanderschueren  et  al.  [35]  compared  the  imaging  (CT
nd  MRI)  appearance  of  patients  treated  with  and  without
uccess  by  thermocoagulation.  In  CT,  it  was  possible  to  see
omplete  ossiﬁcation  of  the  nidus,  persistence  of  a  small
idus,  a  reduction  in  the  diameter  of  the  nidus,  unchanged
iameter  and  thermal  necrosis.  Complete  ossiﬁcation  of  the
idus  or  persistence  of  a  small  nidus  was  seen  in  58%  of  the
atients  treated  with  success,  but  not  in  the  cases  where
he  treatment  had  failed.  The  absence  of  ossiﬁcation  of  the
idus  was  not  correlated  with  failure  of  the  treatment.
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CT  cannot  therefore  be  used  to  evaluate  the  activity  of
the  lesion  after  treatment.  The  value  of  MRI  also  appears
to  be  limited,  since  oedema  and  enhancement  can  persist
(69%  of  oedema  persists  in  successfully  treated  patients).
MRA  sequences  with  subtraction,  which  distinguishes  the
nidus  from  peripheral  bone  oedema,  could  improve  post-
treatment  evaluation  of  osteoid  osteoma.
Clinical  examination  retains  a  central  role  in  assessing
the  response  to  treatment,  identifying  patients  who  might
beneﬁt  from  a  second  procedure.
Conclusion
Interstitial  laser  photocoagulation  is  an  effective  and  safe
treatment  for  osteoid  osteomas.  In  the  case  of  failure  or
recurrence,  treatments  can  be  repeated.  The  main  factors
for  failure  seem  to  be  the  size  of  the  nidus,  sometimes
requiring  the  use  of  several  trajectories,  and  the  position
of  the  trocar  in  the  three  spatial  planes.
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